Trillium Asset Management, LLC Abbott Laboratories Transaction History

Trillium Asset Management, LLC

$3.41 Billion
Q1 2025

A detailed history of Trillium Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Trillium Asset Management, LLC holds 6,120 shares of ABT stock, worth $769,467. This represents 0.02% of its overall portfolio holdings.

Number of Shares

6,120

Previous 6,370 3.92%

Holding current value

$769,467

Previous $720,000 12.64%

% of portfolio

0.02%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$111.1 - $140.22 $27,775 - $35,055	-250 Reduced 3.92%	6,120 $811,000
Q3 2024 Nov 07, 2024	SELL	$100.07 - $118.13 $6,504 - $7,678	-65 Reduced 1.01%	6,370 $726,000
Q2 2024 Aug 07, 2024	SELL	$100.73 - $112.44 $75,446 - $84,217	-749 Reduced 10.43%	6,435 $668,000
Q4 2023 Feb 08, 2024	SELL	$90.19 - $110.4 $39,954 - $48,907	-443 Reduced 5.81%	7,184 $790,000
Q3 2023 Nov 07, 2023	SELL	$95.53 - $114.62 $172,813 - $207,347	-1,809 Reduced 19.17%	7,627 $738,000
Q2 2023 Aug 09, 2023	BUY	$100.78 - $112.29 $31,846 - $35,483	316 Added 3.46%	9,436 $1.03 Million
Q1 2023 May 08, 2023	SELL	$96.86 - $114.01 $110,226 - $129,743	-1,138 Reduced 11.09%	9,120 $923,000
Q4 2022 Feb 07, 2023	SELL	$95.06 - $111.52 $135,175 - $158,581	-1,422 Reduced 12.17%	10,258 $1.13 Million
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $200,293 - $231,902	2,070 Added 21.54%	11,680 $1.13 Million
Q2 2022 Aug 08, 2022	SELL	$102.07 - $123.37 $458,498 - $554,178	-4,492 Reduced 31.85%	9,610 $1.04 Million
Q1 2022 May 04, 2022	BUY	$114.02 - $139.04 $163,390 - $199,244	1,433 Added 11.31%	14,102 $1.67 Million
Q4 2021 Feb 08, 2022	BUY	$115.53 - $141.46 $243,652 - $298,339	2,109 Added 19.97%	12,669 $1.78 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $13,882 - $15,358	119 Added 1.14%	10,560 $1.25 Million
Q2 2021 Aug 06, 2021	SELL	$105.79 - $124.53 $65,589 - $77,208	-620 Reduced 5.61%	10,441 $1.21 Million
Q1 2021 May 10, 2021	BUY	$108.84 - $128.23 $9,142 - $10,771	84 Added 0.77%	11,061 $1.33 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $3,150 - $3,432	-30 Reduced 0.27%	10,977 $1.2 Million
Q3 2020 Nov 09, 2020	BUY	$91.64 - $111.29 $9,164 - $11,129	100 Added 0.92%	11,007 $1.2 Million
Q2 2020 Aug 06, 2020	BUY	$76.57 - $98.0 $562,866 - $720,398	7,351 Added 206.72%	10,907 $997,000
Q1 2020 May 07, 2020	SELL	$62.82 - $91.86 $16,647 - $24,342	-265 Reduced 6.94%	3,556 $281,000
Q4 2019 Feb 10, 2020	SELL	$78.51 - $87.4 $219,513 - $244,370	-2,796 Reduced 42.25%	3,821 $332,000
Q3 2019 Nov 06, 2019	BUY	$81.84 - $88.74 $541,535 - $587,192	6,617 New	6,617 $554,000

Others Institutions Holding ABT

# of Institutions

3,574

Shares Held

1.37B

Call Options Held

9.75M

Put Options Held

8.87M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $220B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trillium Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trillium Asset Management, LLC with notifications on news.

Account

Trillium Asset Management, LLC Abbott Laboratories Transaction History